https://ymaho.com/auvelity-for-dementia-fda-approved-alternative-to-antipsychotics
FDA approved Auvelity for the treatment of agitation in Alzheimer's disease. First non-antipsychotic agent without mortality risk. Learn about the new standard of therapy.